2018 cohort company Macro-Eyes has been awarded a grant by the Vaccine Confidence Fund to build and test a novel machine learning system to predict local vaccine hesitancy among diverse communities in South Africa. Learn more here.
2018 cohort company Ejenta presented at CES on the Future of Healthcare Driven by Spaceflight, discussing how technologies like AR, Extended Reality, and biosensors are being used to effectively diagnose and treat medical needs in space. Learn more here.
2018 cohort company Lapovations recently received approval from the Arkansas Economic Development Commission for the Equity Investment Tax Credit Program and will now begin fundraising efforts for their Series A round to support the national launch of their AbGrab product. Learn more here.
2018 cohort company Day Zero Diagnostics announced the completion of a $21M venture equity financing. To date, Day Zero Diagnostics has raised over $33M in venture capital financing and over $10M in non-dilutive funding. Learn more here.